FDA-Inspected Site

Ajanta Pharma Ltd.

6 FDA inspections are on record for Ajanta Pharma Ltd. in Paithan, India.

483· Form 483 issued

Paithan, India · Last updated August 15, 2026

Overview

  • 6 FDA inspections are on record.
  • 5 inspections produced a Form 483.
  • The most recent recorded inspection date is 2026-04-21.

At a glance

Inspections

6

Form 483s

5

EIRs

0

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
13 Apr 2026 – 21 Apr 2026Human Drugs483View 483 →
26 Feb 2024 – 5 Mar 2024Human DrugsClean
24 Jun 2019 – 28 Jun 2019Human Drugs483On file
30 Jan 2017 – 7 Feb 2017Human Drugs483View 483 →
15 Mar 2015 – 20 Mar 2015Human Drugs483View 483 →
6 Sep 2012Not recorded483On file

Observations on record

Form 483 observations cited at this site, most recent first.

21 Apr 2026
21 CFR 211.100(b)

SOPs not followed / documented

Cited by Tamil Arasu, Nibin Varghese

21 Apr 2026
21 CFR 211.192

Investigations of discrepancies, failures

Cited by Tamil Arasu, Nibin Varghese

21 Apr 2026
21 CFR 211.22(d)

Procedures not in writing, fully followed

Cited by Tamil Arasu, Nibin Varghese

21 Apr 2026
21 CFR 211.63

Equipment Design, Size and Location

Cited by Tamil Arasu, Nibin Varghese

21 Apr 2026
21 CFR 211.67(a)

Cleaning / Sanitizing / Maintenance

Cited by Tamil Arasu, Nibin Varghese

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 211.63Cited across public-safe Form 483 observations4x
21 CFR 211.22(d)Cited across public-safe Form 483 observations3x
21 CFR 211.160(b)Cited across public-safe Form 483 observations2x
21 CFR 211.100(b)Cited across public-safe Form 483 observations1x
21 CFR 211.192Cited across public-safe Form 483 observations1x
21 CFR 211.67(a)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Ajanta Pharma Ltd.'s 5 Form 483s

Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat